Overall and cardiovascular mortality in patients with chronic kidney disease (CKD) is greatly
increased, without obvious current effective treatments. Mineral and bone disorder (MBD) is …

Background Alkaline phosphatase (ALP) and bone-specific ALP (BALP) are implicated in
the abnormal skeletal mineralization and accelerated vascular calcification in chronic kidney …

Background Renal osteodystrophy encompasses the bone histologic abnormalities seen in
patients with chronic kidney disease (CKD). The bone-specific alkaline phosphatase (bALP) …

Increased cardiovascular morbidity and mortality in chronic kidney disease (CKD)
represents an emerging major health problem. Indeed, disturbances in mineral and bone …

Osteoporosis is defined as a condition of impairment in bone strength due to low bone
mineral density and poor bone quality and predisposes individuals to an increased risk of …

Chronic kidney disease (CKD) is accompanied by disturbances in calcium, phosphate,
vitamin D, and parathyroid hormone (PTH) homeostasis that play an important role in the …

Parathyroid hormone (PTH) measurement in serum or plasma is a necessary tool for the
exploration of calcium/phosphate disorders, and is widely used as a surrogate marker to …

Chronic kidney disease mineral bone disorder (CKD-MBD) is a common co-morbidity in
patients with CKD. Characterized by laboratory abnormalities, bone abnormality, and …

Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (CKD-MBD) is a complex
disease that is not completely understood. However, some factors secreted by the …

Assessing bone turnover is a key diagnostic tool in the global management of chronic
kidney disease-mineral and bone disorder (CKD-MBD). Since bone biopsy is invasive and …